Pharmaceuticals: drug regulation in low and middle income countries (English)

Regulation of pharmaceuticals is a complex task. Andreas Seiter's note reviews the role of drug regulatory authorities in developing countries and discusses how to set priorities in line with the overall health policy agenda.. Most diseases in developing countries could be treated with existing and well-known medicines. However, essential pharmaceuticals often are not available, not accessible, or not used appropriately. As bad or worse, use of substandard...

DETAILS

Author

Seiter,Andreas;

de Beyer, Joy [editor];
Document Date
2005/04/01
Document Type
Brief
Report Number
32194
Volume No
1
Total Volume(s)
1
Country
Africa,
Region
Africa,
Disclosure Date
2005/05/04
Disclosure Status
Disclosed
Doc Name
Pharmaceuticals: drug regulation in low and middle income countries
Keywords
economic regulatory framework

DOWNLOADS

COMPLETE REPORT

Official version of document (may contain signatures, etc)

Official PDF
TXT*
Total Downloads** : 1225
Download Stats
*The text version is uncorrected OCR text and is included solely to benefit users with slow connectivity.

Citation

Seiter,Andreas; de Beyer, Joy [editor].

Pharmaceuticals: drug regulation in low and middle income countries (English). HNP brief; no. 4 Washington, DC: World Bank. http://documents.worldbank.org/curated/en/954371468194045308

Pharmaceuticals: drug regulation in low and middle income countries (English)

DETAILS

DOWNLOADS

COMPLETE REPORT

Citation

RELATED LINKS

SUBSCRIBE TO EMAIL ALERTS